- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin-like growth factor binding protein
Total 58734 results
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
Assistance Publique - Hôpitaux de ParisCompletedMild Cognitive Impairment | Alzheimer's Disease | Cognitive Function 1, Social | Control With Normal Activities of Daily LivingFrance
-
University of South CarolinaSusan G. Komen Breast Cancer FoundationCompleted
-
University of AarhusCompleted
-
Assiut UniversityNot yet recruiting
-
Canadian Myeloma Research GroupCompleted
-
National Cancer Institute (NCI)TerminatedRhabdomyosarcoma | Rhabdomyosarcoma, Alveolar | Rhabdomyosarcoma, EmbryonalUnited States
-
Insmed IncorporatedMuscular Dystrophy AssociationCompleted
-
University Hospital, LinkoepingOstergotland County Council, Sweden; Stiftelsen SamaritenActive, not recruitingFetal Growth Retardation | Intrauterine Growth Restriction | IUGRSweden
-
University of JordanCompletedDiagnosis of GHD With IGF-I/IGFBP-3 Ratio
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS); ALS Association and other collaboratorsCompletedAmyotrophic Lateral SclerosisUnited States, Puerto Rico
-
Aarhus University HospitalLaboratory for Proteome Analysis and Protein Characterization, Aarhus UniversityUnknownDiabetes Complications | Polyneuropathies | Insulin-like Growth Factor I | Insulin-like Growth Factor II | Nerve Growth FactorsDenmark
-
University of AarhusCompletedKidney Failure, ChronicDenmark
-
University of RochesterNational Institute of Neurological Disorders and Stroke (NINDS); Imsmed IncorporatedCompleted
-
Insmed IncorporatedTerminated
-
AstraZenecaDaiichi SankyoNot yet recruiting
-
Kite, A Gilead CompanyArcellx, Inc.Not yet recruiting
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
-
Beijing Tiantan HospitalBeijing University of Chemical Technology; Beijing Healthunion Cardio-Cerebrovascular...Not yet recruiting
-
Boston Immune Technologies and TherapeuticsNot yet recruitingPeripheral T-cell Lymphoma | NHL | Cutaneous T Cell Lymphoma
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerAustralia, China, Korea, Republic of, Taiwan
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States
-
BioNTech SEDualityBio Inc.Not yet recruiting
-
Helwan UniversityNot yet recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
-
European Organisation for Research and Treatment...NovartisNot yet recruitingRecurrent Meningioma
-
Jinling Hospital, ChinaRecruitingNewly Diagnosed Multiple MyelomaChina
-
Taizhou HospitalNot yet recruitingLung Cancer, Nonsmall Cell
-
Guangzhou Medical UniversityRecruiting
-
Shanxi Bethune HospitalRecruiting
-
CelgeneNot yet recruitingMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
OncotherapeuticsIncyte CorporationNot yet recruiting
-
Juan LI, MDRecruitingNon Small Cell Lung Cancer | EGFR Exon 20 Insertion MutationChina
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNot yet recruiting
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Myeloma CanadaRecruiting
-
National Cancer Institute (NCI)Recruiting
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
AbbVieRecruiting
-
PfizerRecruiting
-
University of Kansas Medical CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-Small-Cell LungUnited States, Taiwan, Korea, Republic of, Malaysia, Turkey, France, Spain, China, Germany, Argentina
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Taiwan, China, Japan, Canada, Israel, Korea, Republic of, Argentina, Australia, Brazil
-
AbbVieNot yet recruiting
-
Starton Therapeutics, IncRecruitingMultiple MyelomaUnited States